Пациенты с хроническим заболеванием печени и COVID-19 (обзор литературы и собственные данные)

References

Ильченко Л.Ю., Никитин И.Г., Федоров И.Г. COVID-19 и поражение печени. Архив внутренней медицины. 2020;10(3):188- 197. https://doi.org/10.20514/2226-6704-2020-10-3-188-197.

Маев И.В., Бордин Д.С. Ведение пациентов с хроническими заболеваниями печени в условиях пандемии COVID-19 // Методические рекомендации // Москва 2020. – стр- 28.

Маннанова И. В., Понежева Ж. Б., Макашова В. В., Омарова Х. Г., Рейзис А. Р.,Горелов А. В. 2020. некоторые аспекты повреждения печени при инфекции, вызванной sars-cov-2. COVID-19 preprints.microbe.ru.https://doi.org/10.21055/preprints-3111776

Пинчук Т. В., Орлова Н. В., Суранова Т. Г., Бонкало Т. И. Ме¬ханизмы поражения печени при COVID 19. Медицинский алфавит. 2020; (19): 39–46. https://doi.org/10.33667/2078-5631-2020-19-39-46.

Рейзис А. Р., Понежева Ж. Б., Макашова В. В., Омарова Х. Г., Маннанова И. В., Горелов А. В. 2020. Поражение печени при COVID-19. Covid19-preprints.microbe.RU. https://doi.org/10.21055/preprints-3111760

Рейзис А. Р., Понежева Ж. Б., Макашова В. В., Омарова Х. Г., Маннанова И. В., Горелов А. В. 2020. Хронические заболевания печени в период пандемии COVID – 19. Россия.2020. – стр.-1-7.

Akdur A, Karakaya E, Ayvazoglu Soy EH, et al. Coronavirus Disease (COVID-19) in Kidney and Liver Transplant Patients: A Single-Center Experience. Exp Clin Transplant. 2020;18(3):270-274. doi:10.6002/ect.2020.0193

APASL Covid 19 Task Force, Lau G, Sharma M. Clin¬ical practice guidance for hepatology and liver transplant providers during the COVID 19 pan¬demic: APASL expert panel consensus recommen¬dations. Hepatol Int. 2020 Jul; 14 (4): 415–428. DOI: 10.1007/s12072–020–10054-w.

Artru F, Alberio L, Moradpour D, Stalder G. Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis. BMJ Case Rep. 2020;13(7):e236815. Published 2020 Jul 7. doi:10.1136/bcr-2020-236815

Bangash M. N.; Patel J.; Parekh D. COVID 19 and the liver: Little cause for concern. Lancet Gastroenterol. Hepatol. 2020, 5, 529–530. DOI: 10.1016/S 2468–1253(20)30084–4.

Jose RJ, Manuel A. COVID 19 cytokine storm: the interplay between nflammation and co¬agulation. Lancet Respir Med. 2020. https://doi. org/10.1016/S 2213– 2600(20),30216–2.

Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18: 844–7. DOI: 10.1111/jth.14768.

Chau TN, Lee KC, Yao H, Tsang TY, Chow TC, et al. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology. 2004; 39: 302–310. DOI: 10.1002/hep.20111.

Cui Y, Tian M, Huang D, Wang X, Huang Y, et al. A 55-Day-Old Female Infant Infected With 2019 Novel Coronavirus Disease: Presenting With Pneumonia, Liver Injury, and Heart Damage. J Infect Dis. 2020 May 11; 221 (11): 1775–1781. DOI: 10.1093/infdis/jiaa113.

Dahlqvist G, Ciccarelli O, Van Vlierberghe H, et al. Liver transplantation during the COVID-19 epidemic: recommendations from the Belgian Liver Intestine Transplant Committee (BeLIAC). Acta Gastroenterol Belg. 2020;83(2):340-343

doi:10.3748/wjg.v26.i22.29878

El Kassas M, Alboraie M, Al Balakosy A, et al. Liver transplantation in the era of COVID-19. Arab J Gastroenterol. 2020;21(2):69-75. doi:10.1016/j.ajg.2020.04.019

Ghayda RA, Lee J, Lee JY, Kim DK, Lee KH, et al. Correlations of Clinical and Laboratory Charac¬teristics of COVID 19: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2020 17 (14): 5026. DOI: 10.3390/ijerph17145026.

Lang PA, Recher M, Honke N, Scheu S, Borkens S, et al. Tissue macrophages suppress viral rep¬lication and prevent severe immunopathology in an interferon-I-dependent manner in mice. Hepatology. 2010 Jul; 52 (1): 25–32. DOI: 10.1002/ hep.23640.

Musa S. Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID 19): What do we know till now? Arab J Gastroenterol. 2020; 21: 3–8.

Polakos NK, Cornejo JC, Murray DA, Wright KO, Treanor JJ, Crispe IN, et al. Kupffer cell dependent hepatitis occurs during influenza infection. Am J Pathol. 2006; 168 (4): 1169–78.

Sarin SK, Choudhury A, Lau GK, et al. Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study) [published online ahead of print, 2020 Jul 4]. Hepatol Int. 2020;1- 11. doi:10.1007/s12072-020-10072-8

Zhang C.; Shi L.; Wang F. S. Liver injury in COVID 19: Management and challenges. Lan¬cet Gastroenterol. Hepatol. 2020, 5, 428–430. DOI: 10.1016/S 2468–1253(20)30057–1.

Zhao B, Ni C, Gao R, Wang Y, Yang L, Wei J, et al. Recapitulation of SARS-CoV 2 infection and cholangiocyte damage with human liver ductal organoids. Protein Cell. 2020. Oct; 11 (10): 771–775. https://doi.org/10.1007/s13238–020–00718–6

Wu J, Song S, Cao HC, Li LJ. Liver diseases in COVID 19: Etiology, treatment and prognosis. World J Gastroenterol. 2020; 26 (19): 2286–2293. DOI: 10.3748/wjg.v26.i19.2286.

Wu J. et al. Liver diseases in COVID 19: Etiolo¬gy, treatment and prognosis //World Journal of Gastroenterology. 2020. Т. 26. N 19. С. 2286. DOI: 10.3748/wjg.v26.i19.2286.

Yuldasheva D.H. Shadjanova N.S., Oltiboyev R.O. Non-alcoholic fatty liver disease and modern medicine // Academicia an international multidisciplinary research journal // Vol.10. Issue 11. Nov.2020. – P. 1931 – 1937.

Yuldasheva D.H., Zokirov V.Z., G`ulomova Sh.Q. Non-alcoholic fatty liver disease: Modern view of the problem // A Multidisciplinary Peer Reviewed Journal.Vol.6. Issue 12. Dec.2020. – P. 286 – 292.